A clinical trial update was recorded on November 13, 2026, involving leptin. The trial, titled "Strength Training During Pregnancy: The Trial MOVE4TWO," registered under identifier NCT07934862, is currently listed as recruiting. The trial phase is listed as not applicable. No additional details such as results, outcomes, or findings have been provided as part of this update. The recruiting status indicates that the study is actively seeking participants as of the date noted. No efficacy, safety, or benefit information related to leptin is included in this update. This brief reflects only the status and identifying details of the trial as registered. Readers interested in the full trial protocol, eligibility criteria, and sponsor information can consult the official trial listing directly. For further background on leptin as a compound, readers may refer to the compound overview for additional context.
Leptin-Related Trial MOVE4TWO Recruiting for Pregnancy Strength Study
Source: https://clinicaltrials.gov/study/NCT07934862